Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway
International Heart Journal · 2024
DOI: 10.1536/ihj.23-423 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2024. Verfasst von Kelian Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University. Hauptthemen laut MEDLINE: MicroRNAs, Xanthophylls, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Quanzhou First Hospital Affiliated to Fujian Medical University.
- Department of Ultrasound, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian Campus).
Zitieren
APA
Zhang, K., Zhuo, H., Guo, J., Wang, W., & Dai, R. (2024). Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway. International Heart Journal. https://doi.org/10.1536/ihj.23-423
Vancouver
Zhang K, Zhuo H, Guo J, Wang W, Dai R. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway. International Heart Journal. 2024. doi:10.1536/ihj.23-423
BibTeX
@article{Zhang2024,
author = {Zhang, Kelian and Zhuo, Huilin and Guo, Jingyi and Wang, Wei and Dai, Ruozhu},
title = {Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway},
journal = {International Heart Journal},
year = {2024},
doi = {10.1536/ihj.23-423}
}
EUVIMED